- Home
- ECO vs VALN Comparison
ECO vs VALN Comparison
Compare ECO & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECO
- VALN
- Stock Information
- Founded
- ECO 2018
- VALN 2012
- Country
- ECO Greece
- VALN France
- Employees
- ECO N/A
- VALN N/A
- Industry
- ECO
- VALN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ECO
- VALN Health Care
- Exchange
- ECO Nasdaq
- VALN Nasdaq
- Market Cap
- ECO 1.0B
- VALN 820.0M
- IPO Year
- ECO N/A
- VALN 2021
- Fundamental
- Price
- ECO $38.31
- VALN $9.03
- Analyst Decision
- ECO Strong Buy
- VALN Strong Buy
- Analyst Count
- ECO 2
- VALN 4
- Target Price
- ECO $37.00
- VALN $15.75
- AVG Volume (30 Days)
- ECO 231.4K
- VALN 26.2K
- Earning Date
- ECO 11-12-2025
- VALN 11-20-2025
- Dividend Yield
- ECO 5.52%
- VALN N/A
- EPS Growth
- ECO N/A
- VALN N/A
- EPS
- ECO 2.38
- VALN N/A
- Revenue
- ECO $349,886,578.00
- VALN $230,566,060.00
- Revenue This Year
- ECO N/A
- VALN $6.86
- Revenue Next Year
- ECO $21.20
- VALN $11.85
- P/E Ratio
- ECO $15.92
- VALN N/A
- Revenue Growth
- ECO N/A
- VALN 25.47
- 52 Week Low
- ECO $17.91
- VALN $3.62
- 52 Week High
- ECO $39.77
- VALN $12.25
- Technical
- Relative Strength Index (RSI)
- ECO 73.43
- VALN 42.66
- Support Level
- ECO $32.86
- VALN $8.50
- Resistance Level
- ECO $39.77
- VALN $9.50
- Average True Range (ATR)
- ECO 0.92
- VALN 0.27
- MACD
- ECO 0.37
- VALN 0.02
- Stochastic Oscillator
- ECO 81.07
- VALN 55.14
About ECO Okeanis Eco Tankers Corp.
Okeanis Eco Tankers Corp owns and operates tanker vessels in Greece. The business of the company is to own, charter out, and operate tanker vessels. The company owns, through its vessel-owning subsidiaries, a fleet of around seven tanker vessels and has around eight tanker vessels on order. The sailing fleet consists of around six modern Suezmax tankers and eight VLCC tankers.
About VALN Valneva SE
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.